Opposing Roles of Mitogenic and Stress Signaling Pathways in the Induction of Cancer Dormancy

 Abstract

Cancer dormancy is a poorly understood stage of cancer progression. However, the ability to control this step of the disease offers novel therapeutic opportunities. Here we summarize recent findings that implicate the extracellular matrix and adhesion receptor signaling in the escape or induction of tumor dormancy. We further review evidence suggesting that imbalances in the activity ratio of ERK to p38 signaling may determine the fate (i.e. tumorigenicity vs. dormancy) of different carcinoma cells. Special attention is placed on the mechanisms that p38 signaling regulates during the induction of dormancy and how modulation of these pathways may offer a therapeutic opportunity. We also review evidence for a novel drug-resistance mechanism in dormant tumor cells that when blocked may enable killing of dormant tumor cells. Finally, we explore the notion that dormancy of tumor cells may be the result of a selective adaptive response that allows disseminated tumor cells to pause their growth and cope with stress signaling imposed by dissemination and/or treatment until growth can be restored.

Full Text Options
Article
Metrics
 Share
 Full Text
 Info
Pages
1799 - 1807
doi
10.4161/cc.5.16.3109
Type
Spotlight on Cancer Cell Dormancy
 Metrics
 Cite This Article
 Permissions
 Permissions
 Reprints
Opposing Roles of Mitogenic and Stress Signaling Pathways in the Induction of Cancer Dormancy